These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Neurogenic diabetes insipidus: management with dDAVP (1-desamino-8-D arginine vasopressin). Cobb WE; Spare S; Reichlin S Ann Intern Med; 1978 Feb; 88(2):183-8. PubMed ID: 626447 [TBL] [Abstract][Full Text] [Related]
4. [DDAVP in the treatment of acute neurosurgical diabetes insipidus]. Zancaner F; Griner A; Galante E Minerva Med; 1984 Apr; 75(18):1063-7. PubMed ID: 6728257 [TBL] [Abstract][Full Text] [Related]
5. A comparison of plasma vasopressin measurements with a standard indirect test in the differential diagnosis of polyuria. Zerbe RL; Robertson GL N Engl J Med; 1981 Dec; 305(26):1539-46. PubMed ID: 7311993 [TBL] [Abstract][Full Text] [Related]
6. Metastatic breast cancer presenting with diabetes insipidus. Tham LC; Millward MJ; Lind MJ; Cantwell BM Acta Oncol; 1992; 31(6):679-80. PubMed ID: 1466897 [No Abstract] [Full Text] [Related]
7. Postcraniotomy diabetes insipidus: treatment with DDAVP, a synthetic analog of vasopressin. Daneman D; Ehrlich RM; Bailey JD J Pediatr; 1978 Nov; 93(5):879-80. PubMed ID: 712500 [No Abstract] [Full Text] [Related]
8. [Clinical trial of a vasopressin analog, DDAVP, in 4 patients with diabetes insipidus]. Borner W; Froesch ER Schweiz Med Wochenschr; 1974 Apr; 104(16):579-82. PubMed ID: 4827026 [No Abstract] [Full Text] [Related]
9. The use of 1-desamino-8-D-arginine vasopressin (DDAVP) in the management of neurogenic diabetes insipidus (multiple etiologies in pediatric patients). Brown DR; Uden DL Minn Med; 1979 Jun; 62(6):427-32. PubMed ID: 492086 [No Abstract] [Full Text] [Related]
11. [Animal experiment studies of the influence exerted by exsiccosis due to thirst on the development of the neurosecretory hypothalamo-neuro-hypophyseal system]. Rodeck H Acta Neuroveg (Wien); 1966; 29(1):1-44. PubMed ID: 5962447 [No Abstract] [Full Text] [Related]
12. [Clinical use of DDAVP in a case of familial hypothalamo-pituitary diabetes insipidus]. Filipponi P; Nicoletti I; Nunzi E; Benedetti Massi M; Santeusanio F Minerva Med; 1979 Jan; 70(4):347-56. PubMed ID: 431863 [TBL] [Abstract][Full Text] [Related]
13. Treatment of diabetes insipidus with 1-deamino-8-d-arginine vasopressin. Czakó L; Mezei G; László FA Acta Med Acad Sci Hung; 1975; 32(1):75-84. PubMed ID: 1233863 [TBL] [Abstract][Full Text] [Related]
14. Antibodies to vasopressin in patients with diabetes insipidus. Implications for diagnosis and therapy. Vokes TJ; Gaskill MB; Robertson GL Ann Intern Med; 1988 Feb; 108(2):190-5. PubMed ID: 3341651 [TBL] [Abstract][Full Text] [Related]
15. Transient diabetes insipidus in the Landry-Guillain-Barré syndrome. Pessin MS Arch Neurol; 1972 Jul; 27(1):85-6. PubMed ID: 5049683 [No Abstract] [Full Text] [Related]
16. Hereditary vasopressin-resistant urinary concentrating defects in mice. Naik DV; Valtin H Am J Physiol; 1969 Oct; 217(4):1183-90. PubMed ID: 5824320 [No Abstract] [Full Text] [Related]
18. Treatment with new synthetic analogue of vasopressin in diabetes insipidus. Nash H Arch Dis Child; 1973 Dec; 48(12):979-80. PubMed ID: 4765662 [No Abstract] [Full Text] [Related]
19. Vasopressin analog DDAVP in the treatment of diabetes insipidus. Lee WP; Lippe BM; La Franchi SH; Kaplan SA Am J Dis Child; 1976 Feb; 130(2):166-9. PubMed ID: 766613 [TBL] [Abstract][Full Text] [Related]
20. [Experiences with the synthetic vasopressin derivative 1-desamino-8-D-arginine vasopressin (DDAVP) in the therapy of diabetes insipidus]. Schrader D; Frahm H; Freisenhausen HD; Lüdecke D; Krüger HP Verh Dtsch Ges Inn Med; 1976; 82 Pt 2():1909-12. PubMed ID: 1030134 [No Abstract] [Full Text] [Related] [Next] [New Search]